Neuroectodermal neoplasm: Difference between revisions
CSV import |
CSV import |
||
| Line 38: | Line 38: | ||
{{stub}} | {{stub}} | ||
{{No image}} | {{No image}} | ||
__NOINDEX__ | |||
Revision as of 19:50, 17 March 2025
Neuroectodermal neoplasm is a type of tumor that originates from the neuroectoderm, the part of the embryo that develops into the nervous system and the skin.
Overview
Neuroectodermal neoplasms are a broad category of tumors that include both benign (non-cancerous) and malignant (cancerous) growths. They can occur anywhere in the body, but are most commonly found in the brain, spinal cord, and peripheral nerves. These tumors can cause a variety of symptoms, depending on their location and size.
Types
There are several types of neuroectodermal neoplasms, including:
- Neuroblastoma: This is the most common type of neuroectodermal neoplasm in children. It usually starts in the adrenal glands, which are small glands on top of the kidneys.
- Ependymoma: This type of tumor forms in the ependymal cells that line the ventricles of the brain and the center of the spinal cord.
- Medulloblastoma: This is a type of brain tumor that starts in the cerebellum, the part of the brain at the back of the head that controls movement, balance, and coordination.
- Glioma: This is a type of tumor that starts in the glial cells, which support and protect the neurons in the brain and spinal cord.
Diagnosis
Diagnosis of a neuroectodermal neoplasm typically involves a combination of medical history, physical examination, imaging tests such as MRI or CT scan, and often a biopsy to examine the cells under a microscope.
Treatment
Treatment for neuroectodermal neoplasms depends on the type and stage of the tumor, as well as the patient's overall health. Options may include surgery, radiation therapy, chemotherapy, or a combination of these. In some cases, targeted therapies or immunotherapy may be used.
Prognosis
The prognosis for neuroectodermal neoplasms varies widely, depending on factors such as the type and stage of the tumor, the patient's age and overall health, and the effectiveness of treatment.
